The effectiveness unlocks immediate selling by warrant holders, likely pressuring the stock. With a going-concern opinion and no company proceeds, expect continued downward drift. Monitor for insider selling and any operational catalysts that could offset dilution.
Price Chart
Executive Summary
AIM ImmunoTech's S-1 registration (File No. 333-296871) became effective on June 23, 2026, enabling the resale of up to 31,287,933 shares of common stock by selling stockholders. This adds to massive existing warrant overhang (over 37M additional shares from prior warrants) for a company with a ~$10M market cap and a going-concern opinion, creating severe dilution risk.
Key Facts
- S-1 registration effective June 23, 2026 (File No. 333-296871)
- Covers resale of up to 31,287,933 shares by selling stockholders
- Shares include 14,903,840 from Class H Warrants, 894,230 placement agent warrants, 15,038,702 from Class I Warrants, and 451,161 placement agent warrants
- Company receives no proceeds from this resale
- Market cap ~$10M; stock closed at $0.52 on June 5, 2026
- Auditors issued a going-concern opinion
Financial Impact
Potential dilution of up to 31.3M shares against a ~$10M market cap, representing over 300% of current shares outstanding
Risk Factors
- Massive dilution from up to 31.3M new shares hitting the market
- Additional overhang from over 37M shares from prior warrants
- Going-concern opinion raises bankruptcy risk
- No proceeds to company from this resale
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-002094 |
| Document: 9999999995-26-002094-index.html | 9999999995-26-002094 |
| Document: 9999999995-26-002094.txt | 9999999995-26-002094 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 30, 2026 25d ago | DEF 14A | $0.1877 | awaiting T+20 | — | $0.1600 (−14.76%) |
Sep 22, 2026 4w ago | Press Release | $0.2156 $0.1662 | ▼ −22.91% | ▼ −22.35% | $0.1600 (−25.79%) |
Sep 14, 2026 5w ago | 8-K | $0.2100 | awaiting T+20 | — | $0.1600 (+23.81%) |
Aug 11, 2026 10w ago | 8-K | $0.2500 $0.2332 | ▼ −6.72% | ▼ −5.66% | $0.1600 (−36.00%) |
Aug 10, 2026 10w ago | 8-K | $0.2630 | awaiting T+20 | — | $0.1600 (+39.16%) |
Aug 10, 2026 10w ago | Press Release | $0.2630 | awaiting T+20 | — | $0.1600 (+39.16%) |
Aug 5, 2026 11w ago | 8-K | $0.2800 $0.2346 | ▼ −16.21% | ▼ −15.61% | $0.1600 (−42.86%) |
Aug 3, 2026 11w ago | Press Release | $0.2600 $0.2260 | ▼ −13.08% | ▼ −14.31% | $0.1600 (−38.46%) |
Jun 24, 2026 17w ago | EFFECT | $0.3740 $0.2534 | ▲ +32.25% | ▲ +34.18% | $0.1600 (+57.22%) |
Jun 18, 2026 18w ago | S-1 | $0.3799 $0.2730 | ▲ +28.14% | ▲ +28.67% | $0.1600 (+57.88%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers